Scinai Immunotherapeutics LTD F-1 registration statements
The S-1’s counterpart for foreign private issuers registering shares for sale in the United States.
NASDAQ
Scinai Immunotherapeutics Ltd. filed an F-1 registration statement for the resale of up to 4,800,000 American Depositary Shares by YA II PN, Ltd., potentially raising up to $15.0 million for the company.
NASDAQ
Scinai Immunotherapeutics aims to bolster its financial position through a standby equity purchase agreement, potentially raising up to $10 million by offering American Depositary Shares (ADSs) to YA II PN, Ltd.
NASDAQ
Scinai Immunotherapeutics restructures its debt with the European Investment Bank, converting a significant portion into equity, and secures a $10 million standby equity purchase agreement with YA II PN, Ltd.